Literature DB >> 23299821

Drug abuse and stroke.

Ana Catarina Fonseca1, José M Ferro.   

Abstract

Cerebrovascular disorders contribute to the morbidity and disability associated with illicit drug use. Drug abusers have an increased risk of both hemorrhagic and ischemic stroke. In geographic areas with a high prevalence of illicit drug use, drug abuse is a frequent cause of stroke in the young adult. The illicit drugs more commonly associated with stroke are psychomotor stimulants, such as amphetamine and cocaine. Less commonly implicated are opioids and psychotomimetic drugs, including cannabis. Toxicology screening for illicit drugs should be done in young patients with stroke with no obvious cause, or if suggested by history or examination. Although in some patients the mechanism of stroke is identified using neuroimaging and other modern diagnostic tools, in a sizeable fraction of cases the mechanism of stroke remains unclear. Further studies are needed to elucidate the role of hemodynamic and immunologic mechanisms in these cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299821     DOI: 10.1007/s11910-012-0325-0

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  80 in total

1.  Recurrent stroke associated with cannabis use.

Authors:  I Mateo; A Pinedo; M Gomez-Beldarrain; J M Basterretxea; J C Garcia-Monco
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

2.  Heroin inhalation-induced unilateral complete hippocampal stroke.

Authors:  Aurélien Benoilid; Nicolas Collongues; Jérôme de Seze; Fréderic Blanc
Journal:  Neurocase       Date:  2012-05-25       Impact factor: 0.881

3.  The effect of heroin and multiple drug abuse on the electrocardiogram.

Authors:  J Lipski; B Stimmel; E Donoso
Journal:  Am Heart J       Date:  1973-11       Impact factor: 4.749

4.  Carotid artery obstruction following LSD capsule ingestion.

Authors:  J Sobel; O E Espinas; S A Friedman
Journal:  Arch Intern Med       Date:  1971-02

5.  Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy.

Authors:  E P Havranek; K Nademanee; P A Grayburn; E J Eichhorn
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

6.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-1993. A 32-year-old man with the sudden onset of a right-sided headache and left hemiplegia and hemianesthesia.

Authors: 
Journal:  N Engl J Med       Date:  1993-07-08       Impact factor: 91.245

7.  Intracerebral haemorrhage and vasculitis secondary to amphetamine use.

Authors:  V Salanova; R Taubner
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

8.  Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users.

Authors:  Claudia G Sáez; Paulina Olivares; Julio Pallavicini; Olga Panes; Natalia Moreno; Teresa Massardo; Diego Mezzano; Jaime Pereira
Journal:  Thromb Res       Date:  2011-05-23       Impact factor: 3.944

9.  Subarachnoid haemorrhage with "Ecstasy" abuse in a young adult.

Authors:  J Auer; R Berent; T Weber; E Lassnig; B Eber
Journal:  Neurol Sci       Date:  2002-10       Impact factor: 3.307

10.  Acute phencyclidine intoxication: clinical patterns, complications, and treatment.

Authors:  M M McCarron; B W Schulze; G A Thompson; M C Conder; W A Goetz
Journal:  Ann Emerg Med       Date:  1981-06       Impact factor: 5.721

View more
  38 in total

1.  Trends and Outcomes of Cardiovascular Surgery in Patients With Opioid Use Disorders.

Authors:  Krish C Dewan; Karan S Dewan; Jay J Idrees; Suparna M Navale; Brad F Rosinski; Lars G Svensson; A Marc Gillinov; Douglas R Johnston; Faisal Bakaeen; Edward G Soltesz
Journal:  JAMA Surg       Date:  2019-03-01       Impact factor: 14.766

Review 2.  Haemorrhagic stroke related to the use of 4-fluoroamphetamine.

Authors:  C H W Wijers; M C Visser; R T H van Litsenburg; R J M Niesink; R B Willemse; Esther A Croes
Journal:  J Neurol       Date:  2018-05-08       Impact factor: 4.849

Review 3.  Executive (dys)function after stroke: special considerations for behavioral pharmacology.

Authors:  Jessica M Povroznik; Jenny E Ozga; Cole Vonder Haar; Elizabeth B Engler-Chiurazzi
Journal:  Behav Pharmacol       Date:  2018-10       Impact factor: 2.293

4.  Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage.

Authors:  Dionne E Swor; Matthew B Maas; Sandeep S Walia; David P Bissig; Eric M Liotta; Andrew M Naidech; Kwan L Ng
Journal:  Neurology       Date:  2019-05-29       Impact factor: 9.910

5.  Identifying and Addressing the Unmet Health Care Needs of Drug Court Clients.

Authors:  Karen L Dugosh; David S Festinger; Jessica L Lipkin
Journal:  J Subst Abuse Treat       Date:  2016-08-28

6.  Celastrol Dilates and Counteracts Ethanol-Induced Constriction of Cerebral Arteries.

Authors:  Kelsey North; Alexandria Slayden; Steven Mysiewicz; Anna Bukiya; Alex Dopico
Journal:  J Pharmacol Exp Ther       Date:  2020-08-29       Impact factor: 4.030

7.  Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials.

Authors:  Maryam Bashiri; Michael J Mancino; Virginia A Stanick; Jeff Thostenson; Thomas R Kosten; Alison H Oliveto
Journal:  Am J Addict       Date:  2017-11-08

8.  Metabolic syndrome associated with ischemic stroke among the Mexican Hispanic population in the El Paso/US-Mexico border region.

Authors:  Michael F Osborn; Charles C Miller; Ahmed Badr; Jun Zhang
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-02-16       Impact factor: 2.136

9.  Ultrasensitive detection of 3D cerebral microvascular network dynamics in vivo.

Authors:  Yingtian Pan; Jiang You; Nora D Volkow; Kicheon Park; Congwu Du
Journal:  Neuroimage       Date:  2014-09-02       Impact factor: 6.556

10.  Stroke in sports: a case series.

Authors:  Gonçalo M Alexandrino; Joana Damásio; Patrícia Canhão; Ruth Geraldes; Teresa P Melo; Carlos Correia; José M Ferro
Journal:  J Neurol       Date:  2014-06-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.